Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema.

This is a summary of a publication about the 2-year (96-week) results from the PHOTON study, which was published in Ophthalmology .

People who received aflibercept 8 mg received fewer and less frequent eye injections than those who received aflibercept 2 mg.

After 96 weeks, study participants who received aflibercept 8 mg every 12 weeks or longer following 3 initial monthly injections maintained similar improvements in vision, with fewer injections, compared to those treated with aflibercept 2 mg every 8 weeks following 5 initial monthly injections.